Xin Pan
Impact in
- Pharmaceutical Science top 0.05%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 48
- Advanced Drug Delivery Systems 37
- Drug Solubulity and Delivery Systems 28
- Biomaterials 40
- Nanoparticle-Based Drug Delivery 36
- Co-authors
- Chuanbin Wu (215 shared papers)Guilan Quan (82 shared papers)Boyi Niu (18 shared papers)Ying Huang (82 shared papers)Ting Wen (19 shared papers)Chao Tsang Lu (44 shared papers)Kaixin Liao (5 shared papers)Zhengwei Huang (75 shared papers)
- Journals
- Journal of Controlled Release (17 papers)Acta Pharmaceutica Sinica B (16 papers)AAPS PharmSciTech (15 papers)International Journal of Pharmaceutics (14 papers)Pharmaceutics (8 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xin Pan
278 papers receiving 9.8k citations
Xin Pan's Hit Papers
Peers
Comparison fields: 5 of 148
- Pharmaceutical Science 3.2k
- Biomaterials 1.6k
- Drug Discovery 31
- Biomedical Engineering 1.7k
- Rehabilitation 282
Countries citing papers authored by Xin Pan
This map shows the geographic impact of Xin Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Pan more than expected).
Fields of papers citing papers by Xin Pan
This network shows the impact of papers produced by Xin Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Pan. The network helps show where Xin Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 286 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy Hit paper breakdown → | 2021 | 992 |
| 2 | Mesoporous silica nanoparticles for drug and gene delivery Hit paper breakdown → | 2018 | 617 |
| 3 | Bone Tissue Engineering in the Treatment of Bone Defects Hit paper breakdown → | 2022 | 335 |
| 4 | 2020 | 221 | |
| 5 | 2006 | 162 | |
| 6 | 2016 | 152 | |
| 7 | 2021 | 149 | |
| 8 | 2019 | 141 | |
| 9 | 2021 | 133 | |
| 10 | 2015 | 121 | |
| 11 | 2017 | 116 | |
| 12 | 2020 | 116 | |
| 13 | 2015 | 115 | |
| 14 | 2021 | 115 | |
| 15 | 2020 | 108 | |
| 16 | 2005 | 106 | |
| 17 | 2021 | 105 | |
| 18 | 2023 | 104 | |
| 19 | 2013 | 100 | |
| 20 | 2020 | 99 |
About Xin Pan
Xin Pan is a scholar working on Pharmaceutical Science, Biomaterials, Pulmonary and Respiratory Medicine, Biomedical Engineering and Molecular Medicine, having authored 286 papers that have together received 9.9k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (48 papers), Inhalation and Respiratory Drug Delivery (42 papers), Advanced Drug Delivery Systems (37 papers), Nanoparticle-Based Drug Delivery (36 papers), Nanoplatforms for cancer theranostics (30 papers), Drug Solubulity and Delivery Systems (28 papers), Hydrogels: synthesis, properties, applications (11 papers) and Antimicrobial agents and applications (9 papers). The work is most often cited by research in Pharmaceutical Science (3.2k citations), Biomaterials (1.6k citations), Drug Discovery (31 citations), Biomedical Engineering (1.7k citations) and Rehabilitation (282 citations). Xin Pan has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Chuanbin Wu, Guilan Quan, Boyi Niu, Ying Huang, Ting Wen, Chao Tsang Lu, Kaixin Liao, Zhengwei Huang, Minglong Chen and Tingting Peng. Their work appears in journals such as Journal of Controlled Release, Acta Pharmaceutica Sinica B, AAPS PharmSciTech, International Journal of Pharmaceutics and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.